Gene carriers and transfection systems used in the recombination of dendritic cells for effective cancer immunotherapy

Clinical and Developmental Immunology

Volumn 2010, Issue , 2010, Pages

  Gao, Jian Qing ^a   Chen, Yu Zhe ^a   Yao, Xing Lei ^a   Tabata, Yasuhiko ^b   Nakagawa, Shinsaku ^c  

^a ZHEJIANG UNIVERSITY   (China)

^b KYOTO UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CANCER VACCINE; LENTIVIRUS VECTOR; LIPOSOME; RETROVIRUS VECTOR; INTERLEUKIN 2; TUMOR ANTIGEN;

CANCER IMMUNOTHERAPY; DENDRITIC CELL; DNA PROTEIN COMPLEX; GENE DELIVERY SYSTEM; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; ANIMAL; ANIMAL MODEL; GENE VECTOR; GENETIC RECOMBINATION; GENETICS; IMMUNOLOGY; IMMUNOTHERAPY; METABOLISM; METHODOLOGY; NEOPLASM;

ANIMALS; ANTIGENS, NEOPLASM; CANCER VACCINES; DENDRITIC CELLS; GENETIC VECTORS; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-2; MODELS, ANIMAL; NEOPLASMS; RECOMBINATION, GENETIC; TRANSFECTION;

EID: 79251586236     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2010/565643     Document Type: Review

References (141)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M. J., Cancer statistics, 2009 CA Cancer Journal for Clinicians 2009 59 4 225 249
2. Hinz T., Buchholz C. J., Van Der Stappen T., Cichutek K., Kalinke U., Manufacturing and quality control of cell-based tumor vaccines: a scientific and a regulatory perspective Journal of Immunotherapy 2006 29 5 472 476
3. Palena C., Abrams S. I., Schlom J., Hodge J. W., Cancer vaccines: preclinical studies and novel strategies Advances in Cancer Research 2006 95 115 145
4. Dudziak D., Kamphorst A. O., Heidkamp G. F., Buchholz V. R., Trumpfheller C., Yamazaki S., Cheong C., Liu K., Lee H. W., Chae G. P., Steinman R. M., Nussenzweig M. C., Differential antigen processing by dendritic cell subsets in vivo Science 2007 315 5808 107 111
5. Dhodapkar M. V., Dhodapkar K. M., Palucka A. K., Interactions of tumor cells with dendritic cells: balancing immunity and tolerance Cell Death and Differentiation 2008 15 1 39 50
6. Janeway C. A., Medzhitov R., Innate immune recognition Annual Review of Immunology 2002 20 197 216
7. Itano A. A., Jenkins M. K., Antigen presentation to naive CD4 T cells in the lymph node Nature Immunology 2003 4 8 733 739
8. Randolph G. J., Angeli V., Swartz M. A., Dendritic-cell trafficking to lymph nodes through lymphatic vessels Nature Reviews Immunology 2005 5 8 617 628
9. Inaba K., Metlay J. P., Crowley M. T., Steinman R. M., Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ Journal of Experimental Medicine 1990 172 2 631 640
10. Paczesny S., Ueno H., Fay J., Banchereau J., Palucka A. K., Dendritic cells as vectors for immunotherapy of cancer Seminars in Cancer Biology 2003 13 6 439 447
11. Rughetti A., Biffoni M., Sabbatucci M., Rahimi H., Pellicciotta I., Fattorossi A., Pierelli L., Scambia G., Lavitrano M., Frati L., Nuti M., Transfected human dendritic cells to induce antitumor immunity Gene Therapy 2000 7 17 1458 1466
12. Engelhard V. H., Bullock T. N. J., Colella T. A., Sheasley S. L., Mullins D. W., Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy Immunological Reviews 2002 188 136 146
13. Shevach E. M., Fatal attraction: tumors beckon regulatory T cells Nature Medicine 2004 10 9 900 901
14. Zhang X., Gordon J. R., Xiang J., Advances in dendritic cell-based vaccine of cancer Cancer Biotherapy and Radiopharmaceuticals 2002 17 6 601 619
15. Sallusto F., Lanzavecchia A., Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor Journal of Experimental Medicine 1994 179 4 1109 1118
16. Villadangos J. A., Heath W. R., Carbone F. R., Outside looking in: the inner workings of the crosspresentation pathway within dendritic cells Trends in Immunology 2007 28 2 45 47
17. Shortman K., Naik S. H., Steady-state and inflammatory dendritic-cell development Nature Reviews Immunology 2007 7 1 19 30
18. Dubois B., Bridon J. M., Fayette J., Barthelemy C., Banchereau J., Caux C., Brire F., Dendritic cells directly modulate B cell growth and differentiation Journal of Leukocyte Biology 1999 66 2 224 230
19. Shortman K., Liu Y. J., Mouse and human dendritic cell subtypes Nature Reviews Immunology 2002 2 3 151 161
20. Merad M., Manz M. G., Dendritic cell homeostasis Blood 2009 113 15 3418 3427
21. Maldonado-López R., De Smedt T., Pajak B., Heirman C., Thielemans K., Leo O., Urbain J., Maliszewski C. R., Moser M., Role of CD8 and CD8 dendritic cells in the induction of primary immune responses in vivo Journal of Leukocyte Biology 1999 66 2 242 246
22. Pulendran B., Smith J. L., Caspary G., Brasel K., Pettit D., Maraskovsky E., Maliszewski C. R., Distinct dendritic cell subsets differentially regulate the class of immune response in vivo Proceedings of the National Academy of Sciences of the United States of America 1999 96 3 1036 1041
23. Wilson N. S., Villadangos J. A., Regulation of antigen presentation and cross-presentation in the dendritic cell network: facts, hypothesis, and immunological implications Advances in Immunology 2005 86 241 305
24. Reis e Sousa C., Dendritic cells in a mature age Nature Reviews Immunology 2006 6 6 476 483
25. Villadangos J. A., Heath W. R., Life cycle, migration and antigen presenting functions of spleen and lymph node dendritic cells: limitations of the Langerhans cells paradigm Seminars in Immunology 2005 17 4 262 272
26. Akira S., Takeda K., Toll-like receptor signalling Nature Reviews Immunology 2004 4 7 499 511
27. Kondo H., Hazama S., Kawaoka T., Yoshino S., Yoshida S., Tokuno K., Takashima M., Ueno T., Hinoda Y., Oka M., Adoptive immunotherapy for pancreatic cancer using MUC1 peptide-pulsed dendritic cells and activated T lymphocytes Anticancer Research 2008 28 1 379 387
28. Meylan E., Tschopp J., Karin M., Intracellular pattern recognition receptors in the host response Nature 2006 442 7098 39 44
29. Salgame P., Abrams J. S., Clayberger C., Goldstein H., Convit J., Modlin R. L., Bloom B. R., Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones Science 1991 254 5029 279 282
30. Caux C., Massacrier C., Vanbervliet B., Dubois B., Van Kooten C., Durand I., Banchereau J., Activation of human dendritic cells through CD40 cross-linking Journal of Experimental Medicine 1994 180 4 1263 1272
31. Macagno A., Napolitani G., Lanzavecchia A., Sallusto F., Duration, combination and timing: the signal integration model of dendritic cell activation Trends in Immunology 2007 28 5 227 233
32. Schoenberger S. P., Toes R. E. M., Van Dervoort E. I. H., Offringa R., Melief C. J. M., T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD4OL interactions Nature 1998 393 6684 480 483
33. Pierre P., Turley S. J., Gatti E., Hull M., Meltzer J., Mirza A., Inaba K., Steinman R. M., Mellman I., Developmental regulation of MHC class II transport in mouse dendritic cells Nature 1997 388 6644 787 792
34. Engell-Noerregaard L., Hansen T. H., Andersen M. H., Thor Straten P., Svane I. M., Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters Cancer Immunology, Immunotherapy 2009 58 1 1 14
35. Gilboa E., DC-based cancer vaccines Journal of Clinical Investigation 2007 117 5 1195 1203
36. Kaech S. M., Ahmed R., Immunology: CD8 T cells remember with a little help Science 2003 300 5617 263 265
37. Kawamura K., Kadowaki N., Suzuki R., Udagawa S., Kasaoka S., Utoguchi N., Kitawaki T., Sugimoto N., Okada N., Maruyama K., Uchiyama T., Dendritic cells that endocytosed antigen-containing IgG-liposomes elicit effective antitumor immunity Journal of Immunotherapy 2006 29 2 165 174
38. Trombetta E. S., Mellman I., Cell biology of antigen processing in vitro and in vivo Annual Review of Immunology 2005 23 975 1028
39. Heath W. R., Belz G. T., Behrens G. M. N., Smith C. M., Forehan S. P., Parish I. A., Davey G. M., Wilson N. S., Carbone F. R., Villadangos J. A., Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens Immunological Reviews 2004 199 9 26
40. Ochsenbein A. F., Sierro S., Odermatt B., Pericin M., Karrer U., Hermans J., Hemmi S., Hengartner H., Zinkernagel R. M., Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction Nature 2001 411 6841 1058 1064
41. Willimsky G., Blankenstein T., Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance Nature 2005 437 7055 141 146
42. Raychaudhuri S., Rock K. L., Fully mobilizing host defense: building better vaccines Nature Biotechnology 1998 16 11 1025 1033
43. Bangari D. S., Mittal S. K., Current strategies and future directions for eluding adenoviral vector immunity Current Gene Therapy 2006 6 2 215 226
44. Tuettenberg A., Becker C., Huter E., Knop J., Enk A. H., Jonuleit H., Induction of strong and persistent MelanA/MART-1-specific immune responses by adjuvant dendritic cell-based vaccination of stage II melanoma patients International Journal of Cancer 2006 118 10 2617 2627
45. Babatz J., Rllig C., Lbel B., Folprecht G., Haack M., Gnther H., Khne C. H., Ehninger G., Schmitz M., Bornhuser M., Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cells Cancer Immunology, Immunotherapy 2006 55 3 268 276
46. Bae M. Y., Cho N. H., Seong S. Y., Protective anti-tumour immune responses by murine dendritic cells pulsed with recombinant Tat-carcinoembryonic antigen derived from Escherichia coli Clinical and Experimental Immunology 2009 157 1 128 138
47. Kim D. K., Lee T. V., Castilleja A., Anderson B. W., Peoples G. E., Kudelka A. P., Murray J. L., Sittisomwong T., Wharton J. T., Kim J. W., Ioannides C. G., Folate binding protein peptide 191-199 presented on dendritic cells can stimulate CTL from ovarian and breast cancer patients Anticancer Research 1999 19 4 2907 2916
48. Kim D. K., Kim J. H., Kim Y. T., Kim J. W., Ioannides C. G., The comparoison of cytotoxic T-lymphocyte effects of dendritic cells stimulated by the folate binding protein peptide cultured with IL-15 and IL-2 in solid tumor Yonsei Medical Journal 2002 43 6 691 700
49. Garetto S., Sizzano F., Brusa D., Tizzani A., Malavasi F., Matera L., Binding of prostate-specific membrane antigen to dendritic cells: a critical step in vaccine preparation Cytotherapy 2009 11 8 1090 1100
50. Waeckerle-Men Y., Uetz-Von Allmen E., Fopp M., Von Moos R., Bhme C., Schmid H. P., Ackermann D., Cerny T., Ludewig B., Groettrup M., Gillessen S., Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma Cancer Immunology, Immunotherapy 2006 55 12 1524 1533
51. Yang H., Cho N. H., Seong S. Y., The Tat-conjugated N-terminal region of mucin antigen 1 (MUC1) induces protective immunity against MUC1-expressing tumours Clinical and Experimental Immunology 2009 158 2 174 185
52. Wierecky J., Mueller M., Brossart P., Dendritic cell-based cancer immunotherapy targeting MUC-1 Cancer Immunology, Immunotherapy 2006 55 1 63 67
53. Woo S. J., Kim C. H., Park M. Y., Kim H. S., Sohn H. J., Park J. S., Kim H. J., Oh S. T., Kim T. G., Co-administration of carcinoembryonic antigen and HIV TAT fusion protein with CpG-oligodeoxynucleotide induces potent antitumor immunity Cancer Science 2008 99 5 1034 1039
54. Fong L., Engleman E. G., Dendritic cells in cancer immunotherapy Annual Review of Immunology 2000 18 245 273
55. Schott M., Feldkamp J., Schattenberg D., Krueger T., Dotzenrath C., Seissler J., Scherbaum W. A., Induction of cellular immunity in a parathyroid carcinoma treated with tumor lysate-pulsed dendritic cells European Journal of Endocrinology 2000 142 3 300 306
56. Schnurr M., Galambos P., Scholz C., Then F., Dauer M., Endres S., Eigler A., Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines Cancer Research 2001 61 17 6445 6450
57. Zhao X., Wei Y. Q., Peng Z. L., Induction of T cell responses against autologous ovarian tumors with whole tumor cell lysate-pulsed dendritic cells Immunological Investigations 2001 30 1 33 45
58. Inzkirweli N., Gckel B., Sohn C., Wallwiener D., Bastert G., Lindner M., Antigen loading of dendritic cells with apoptotic tumor cell-preparations is superior to that using necrotic cells or tumor lysates Anticancer Research 2007 27 4 2121 2129
59. Boczkowski D., Nair S. K., Snyder D., Gilboa E., Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo Journal of Experimental Medicine 1996 184 2 465 472
60. Ashley D. M., Faiola B., Nair S., Hale L. P., Bigner D. D., Gilboa E., Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors Journal of Experimental Medicine 1997 186 7 1177 1182
61. Tyagi R. K., Mangal S., Garg N., Sharma P. K., RNA-based immunotherapy of cancer: role and therapeutic implications of dendritic cells Expert Review of Anticancer Therapy 2009 9 1 97 114
62. Hernando J. J., Park T. W., Fischer H. P., Zivanovic O., Braun M., Plcher M., Grnn U., Leutner C., Ptzsch B., Kuhn W., Vaccination with dendritic cells transfected with mRNA-encoded folate-receptor- for relapsed metastatic ovarian cancer Lancet Oncology 2007 8 5 451 454
63. Chen L., Tang X. D., Yu S. T., Ai Z. H., Fang D. C., Cai Y. G., Luo Y. H., Liang G. P., Yang S. M., Induction of anti-tumour immunity by dendritic cells transduced with hTERT recombinant adenovirus in mice Journal of Pathology 2009 217 5 685 692
64. Kim C. H., Yoon J. S., Sohn H. J., Kim C. K., Paik S. Y., Hong Y. K., Kim T. G., Direct vaccination with pseudotype baculovirus expressing murine telomerase induces anti-tumor immunity comparable with RNA-electroporated dendritic cells in a murine glioma model Cancer Letters 2007 250 2 276 283
65. Weissman D., Ni H., Scales D., Dude A., Capodici J., McGibney K., Abdool A., Isaacs S. N., Cannon G., Kariko K., HIV gag mRNA transfection of dendritic cells (DC) delivers encoded antigen to MHC class I and II molecules, causes DC maturation, and induces a potent human in vitro primary immune response Journal of Immunology 2000 165 8 4710 4717
66. Nicolette C. A., Healey D., Tcherepanova I., Whelton P., Monesmith T., Coombs L., Finke L. H., Whiteside T., Miesowicz F., Dendritic cells for active immunotherapy: optimizing design and manufacture in order to develop commercially and clinically viable products Vaccine 2007 25 2 B47 B60
67. Boczkowski D., Nair S., RNA as performance-enhancers for dendritic cells Expert Opinion on Biological Therapy 2010 10 4 563 574
68. Morse M. A., Lyerly H. K., DNA and RNA modified dendritic cell vaccines World Journal of Surgery 2002 26 7 819 825
69. Van Tendeloo V. F. I., Ponsaerts P., Lardon F., Nijs G., Lenjou M., Van Broeckhoven C., Van Bockstaele D. R., Berneman Z. N., Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells Blood 2001 98 1 49 56
70. Ribas A., Genetically modified dendritic cells for cancer immunotherapy Current Gene Therapy 2005 5 6 619 628
71. Mack C. A., Song W. R., Carpenter H., Wickham T. J., Kovesdi I., Harvey B. G., Magovern C. J., Isom O. W., Rosengart T., Falck-Pedersen E., Hackett N. R., Crystal R. G., Mastrangeli A., Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype Human Gene Therapy 1997 8 1 99 109
72. Wu T. L., Ertl H. C. J., Immune barriers to successful gene therapy Trends in Molecular Medicine 2009 15 1 32 39
73. Okada N., Saito T., Masunaga Y., Tsukada Y., Nakagawa S., Mizuguchi H., Mori K., Okada Y., Fujita T., Hayakawa T., Mayumi T., Yamamoto A., Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells Cancer Research 2001 61 21 7913 7919
74. Mizuguchi H., Hayakawa T., Targeted adenovirus vectors Human Gene Therapy 2004 15 11 1034 1044
75. Eto Y., Yoshioka Y., Mukai Y., Okada N., Nakagawa S., Development of PEGylated adenovirus vector with targeting ligand International Journal of Pharmaceutics 2008 354 1-2 3 8
76. Yao X., Yoshioka Y., Morishige T., Eto Y., Watanabe H., Okada Y., Mizuguchi H., Mukai Y., Okada N., Nakagawa S., Systemic administration of a PEGylated adenovirus vector with a cancer-specific promoter is effective in a mouse model of metastasis Gene Therapy 2009 16 12 1395 1404
77. Edelstein M. L., Abedi M. R., Wixon J., Edelstein R. M., Gene therapy clinical trials worldwide 19892004an overview Journal of Gene Medicine 2004 6 6 597 602
78. Adams W. C., Bond E., Havenga M. J. E., Holterman L., Goudsmit J., Hedestam G. B. K., Koup R. A., Lor K., Adenovirus serotype 5 infects human dendritic cells via a coxsackievirus-adenovirus receptor-independent receptor pathway mediated by lactoferrin and DC-SIGN Journal of General Virology 2009 90 7 1600 1610
79. Okada N., Iiyama S., Okada Y., Mizuguchi H., Hayakawa T., Nakagawa S., Mayumi T., Fujita T., Yamamoto A., Immunological properties and vaccine efficacy of murine dendritic cells simultaneously expressing melanoma-associated antigen and interleukin-12 Cancer Gene Therapy 2005 12 1 72 83
80. Okada N., Mori N., Koretomo R., Okada Y., Nakayama T., Yoshie O., Mizuguchi H., Hayakawa T., Nakagawa S., Mayumi T., Fujita T., Yamamoto A., Augmentation of the migratory ability of DC-based vaccine into regional lymph nodes by efficient CCR7 gene transduction Gene Therapy 2005 12 2 129 139
81. Lundqvist A., Choudhury A., Nagata T., Andersson T., Quinn G., Fong T., Maitland N., Pettersson S., Paulie S., Pisa P., Recombinant adenovirus vector activates and protects human monocyte-derived dendritic cells from apoptosis Human Gene Therapy 2002 13 13 1541 1549
82. Schumacher L., Ribas A., Dissette V. B., McBride W. H., Mukherji B., Economou J. S., Butterfield L. H., Human dendritic cell maturation by adenovirus transduction enhances tumor antigen-specific T-cell responses Journal of Immunotherapy 2004 27 3 191 200
83. Youlin K., Xiaodong W., Xiuheng L., Hengchen Z., Zhiyuan C., Botao J., Hui C., Anti-tumor immune response induced by dendritic cells transduced with truncated PSMA IRES 4-1BBL recombinant adenoviruses Cancer Letters 2010 293 2 254 262
84. Kim S., Lee J. B., Geon K. L., Chang J., Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer Prostate 2009 69 9 938 948
85. Jiang N., Wang G. S., Li H., Zhang J., Zhang J. F., Yi S. H., Yi H. M., Yang Y., Cai C. J., Lu M. Q., Chen G. H., Immunization with dendritic cells infected with mTERT adenovirus vector effectively elicits immunity against mouse H22 hepatoma in vivo Zhonghua Zhong Liu Za Zhi 2009 31 6 405 409
86. Gonzalez-Carmona M. A., Lukacs-Kornek V., Timmerman A., Shabani S., Kornek M., Vogt A., Yildiz Y., Sievers E., Schmidt-Wolf I. G. H., Caselmann W. H., Sauerbruch T., Schmitz V., CD40Ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo Hepatology 2008 48 1 157 168
87. Yang J. Y., Cao D. Y., Xue Y., Yu Z. C., Liu W. C., Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells Human Immunology 2010 71 3 255 262
88. Zhu X. P., Chen Z. Z., Li C. T., Lin X., Zhuang J. L., Hu J. D., Yang T., Xu Z. S., In vitro inducing effect of dendritic cells cotransfected with survivin and granulocyte-macrophage colony-stimulating factor on cytotoxic T cell to kill leukemic cells Chinese Medical Journal 2008 121 21 2180 2184
89. Tsai B. Y., Lin Y. L., Chiang B. L., Application of interleukin-12 expressing dendritic cells for the treatment of animal model of leukemia Experimental Biology and Medicine 2009 234 8 952 960
90. Huang J. H., Zhang S. N., Choi K. J., Choi IL. K., Kim J. H., Lee M., Kim H., Yun C. O., Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL Molecular Therapy 2010 18 2 264 274
91. Xie J., Xiong L., Tao X., Li X., Su Y., Hou X., Shi H., Antitumor effects of murine bone marrow-derived dendritic cells infected with xenogeneic livin recombinant adenoviral vectors against Lewis lung carcinoma Lung Cancer 2010 68 3 338 345
92. Kikkawa K., Fujii R., Kuramoto T., Mori T., Inagaki T., Kohjimoto Y., Iwahashi M., Yamaue H., Hara I., Dendritic cells with transduced survivin gene induce specific cytotoxic T lymphocytes in human urologic cancer cell lines Urology 2009 74 1 222 228
93. Bello-Fernandez C., Matyash M., Strobl H., Efficient retrovirus-mediated gene transfer of dendritic cells generated from CD34+ cord blood cells under serum-free conditions Human Gene Therapy 1997 8 14 1651 1658
94. Szabolcs P., Gallardo H. F., Ciocon D. H., Sadelain M., Young J. W., Retrovirally transduced human dendritic cells express a normal phenotype and potent T-cell stimulatory capacity Blood 1997 90 6 2160 2167
95. Bushman F. D., Integration site selection by lentiviruses: biology and possible control Current Topics in Microbiology and Immunology 2002 261 165 177
96. Goujon C., Jarrosson-Wuillme L., Bernaud J., Rigal D., Darlix J. L., Cimarelli A., With a little help from a friend: increasing HIV transduction of monocyte-derived dendritic cells with virion-like particles of SIV Gene Therapy 2006 13 12 991 994
97. Goujon C., Rivire L., Jarrosson-Wuilleme L., Bernaud J., Rigal D., Darlix J. L., Cimarelli A., SIV/HIV-2 Vpx proteins promote retroviral escape from a proteasome-dependent restriction pathway present in human dendritic cells Retrovirology 2007 4, article 2
98. Esslinger C., Romero P., Macdonald H. R., Efficient transduction of dendritic cells and induction of a T-cell response by third-generation lentivectors Human Gene Therapy 2002 13 9 1091 1100
99. Li G. B., Lu G. X., Gene delivery efficiency in bone marrow-derived dendritic cells: comparison of four methods and optimization for lentivirus transduction Molecular Biotechnology 2009 43 3 250 256
100. Han S., Chang L. J., Immunity of lentiviral vector-modified dendritic cells Methods in Molecular Biology 2009 542 245 259
101. Yang L., Yang H., Rideout K., Cho T., Joo K. I., Ziegler L., Elliot A., Walls A., Yu D., Baltimore D., Wang P., Engineered lentivector targeting of dendritic cells for in vivo immunization Nature Biotechnology 2008 26 3 326 334
102. Breckpot K., Emeagi P., Dullaers M., Michiels A., Heirman C., Thielemans K., Activation of immature monocyte-derived dendritic cells after transduction with high doses of lentiviral vectors Human Gene Therapy 2007 18 6 536 546
103. Stripecke R., Lentiviral vector-mediated genetic programming of mouse and human dendritic cells Methods in Molecular Biology 2009 506 139 158
104. Zhang L., Procuik M., Fang T., Kung S. K. P., Functional analysis of the quantitative expression of a costimulatory molecule on dendritic cells using lentiviral vector-mediated RNA interference Journal of Immunological Methods 2009 344 2 87 97
105. Zhang Y., Yang H., Xiao B., Wu M., Zhou W., Li J., Li G., Christadoss P., Dendritic cells transduced with lentiviral-mediated RelB-specific ShRNAs inhibit the development of experimental autoimmune myasthenia gravis Molecular Immunology 2009 46 4 657 667
106. Veron P., Boutin S., Bernard J., Danos O., Davoust J., Masurier C., Efficient transduction of monocyte- and CD34+- derived Langerhans cells with lentiviral vectors in the absence of phenotypic and functional maturation Journal of Gene Medicine 2006 8 8 951 961
107. Hacein-Bey-Abina S., Von Kalle C., Schmidt M., Le Deist F., Wulffraat N., McIntyre E., Radford I., Villeval J. -L., Fraser C. C., Cavazzana-Calvo M., Fischer A., A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency The New England Journal of Medicine 2003 348 3 255 256
108. Ren J., Jia J., Zhang H., Zhang L., Ma B., Jiang H., Di L., Song G., Yu J., Dendritic cells pulsed with -fetoprotein and mutant P53 fused gene induce bi-targeted cytotoxic T lymphocyte response against hepatic carcinoma Cancer Science 2008 99 7 1420 1426
109. Antonia S. J., Mirza N., Fricke I., Chiappori A., Thompson P., Williams N., Bepler G., Simon G., Janssen W., Lee JI. H., Menander K., Chada S., Gabrilovich D. I., Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer Clinical Cancer Research 2006 12 3 878 887
110. Foged C., Arigita C., Sundblad A., Jiskoot W., Storm G., Frokjaer S., Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition Vaccine 2004 22 15-16 1903 1913
111. Yamada M., Nishikawa M., Kawakami S., Hattori Y., Nakano T., Yamashita F., Hashida M., Tissue and intrahepatic distribution and subcellular localization of a mannosylated lipoplex after intravenous administration in mice Journal of Controlled Release 2004 98 1 157 167
112. Lu Y., Kawakami S., Yamashita F., Hashida M., Development of an antigen-presenting cell-targeted DNA vaccine against melanoma by mannosylated liposomes Biomaterials 2007 28 21 3255 3262
113. Hattori Y., Kawakami S., Nakamura K., Yamashita F., Hashida M., Efficient gene transfer into macrophages and dendritic cells by in vivo gene delivery with mannosylated lipoplex via the intraperitoneal route Journal of Pharmacology and Experimental Therapeutics 2006 318 2 828 834
114. Suzuki R., Oda Y., Utoguchi N., Namai E., Taira Y., Okada N., Kadowaki N., Kodama T., Tachibana K., Maruyama K., A novel strategy utilizing ultrasound for antigen delivery in dendritic cell-based cancer immunotherapy Journal of Controlled Release 2009 133 3 198 205
115. Zheng X., Vladau C., Zhang X., Suzuki M., Ichim T. E., Zhang Z. X., Li M., Carrier E., Garcia B., Jevnikar A. M., Min W. P., A novel in vivo siRNA delivery system specifically targeting dendritic cells and silencing CD40 genes for immunomodulation Blood 2009 113 12 2646 2654
116. Orlacchio A., Martino S., Di Girolamo I., Tiribuzi R., D'Angelo F., Datti A., Efficient siRNA delivery by the cationic liposome DOTAP in human hematopoietic stem cells differentiating into dendritic cells Journal of Biomedicine and Biotechnology 2009 2009
117. Yoshikawa T., Imazu S., Gao J. Q., Hayashi K., Tsuda Y., Shimokawa M., Sugita T., Niwa T., Oda A., Akashi M., Tsutsumi Y., Mayumi T., Nakagawa S., Augmentation of antigen-specific immune responses using DNA-fusogenic liposome vaccine Biochemical and Biophysical Research Communications 2004 325 2 500 505
118. Yuba E., Kojima C., Sakaguchi N., Harada A., Koiwai K., Kono K., Gene delivery to dendritic cells mediated by complexes of lipoplexes and pH-sensitive fusogenic polymer-modified liposomes Journal of Controlled Release 2008 130 1 77 83
119. Weecharangsan W., Opanasopit P., Ngawhirunpat T., Apirakaramwong A., Rojanarata T., Ruktanonchai U., Lee R. J., Evaluation of chitosan salts as non-viral gene vectors in CHO-K1 cells International Journal of Pharmaceutics 2008 348 1-2 161 168
120. Lavertu M., Mthot S., Tran-Khanh N., Buschmann M. D., High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation Biomaterials 2006 27 27 4815 4824
121. Dastan T., Turan K., In vitro characterization and delivery of chitosan-DNA microparticles into mammalian cells Journal of Pharmacy and Pharmaceutical Sciences 2004 7 2 205 214
122. Kim T. H., Nah J. W., Cho M. H., Park T. G., Cho N. S., Receptor-mediated gene delivery into antigen presenting cells using mannosylated chitosan/DNA nanoparticles Journal of Nanoscience and Nanotechnology 2006 6 9-10 2796 2803
123. Kim T. H., Jin H., Kim H. W., Cho M. H., Cho C. S., Mannosylated chitosan nanoparticle-based cytokine gene therapy suppressed cancer growth in BALB/c mice bearing CT-26 carcinoma cells Molecular Cancer Therapeutics 2006 5 7 1723 1732
124. Zhou X., Liu B., Yu X., Zha X., Zhang X., Chen YU., Wang X., Jin Y., Wu Y., Chen Y., Shan Y., Chen Y., Liu J., Kong W., Shen J., Controlled release of PEI/DNA complexes from mannose-bearing chitosan microspheres as a potent delivery system to enhance immune response to HBV DNA vaccine Journal of Controlled Release 2007 121 3 200 207
125. Ng S. C., Plamondon S., Kamm M. A., Hart A. L., Al-Hassi H. O., Guenther T., Stagg A. J., Knight S. C., Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis Inflammatory Bowel Diseases 2010 16 8 1286 1298
126. Kanazawa T., Takashima Y., Murakoshi M., Nakai Y., Okada H., Enhancement of gene transfection into human dendritic cells using cationic PLGA nanospheres with a synthesized nuclear localization signal International Journal of Pharmaceutics 2009 379 1-2 187 195
127. Wang C., Ge Q., Ting D., Nguyen D., Shen H. R., Chen J., Eisen H. N., Heller J., Langer R., Putnam D., Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines Nature Materials 2004 3 3 190 196
128. Thiele L., Merkle H. P., Walter E., Phagocytosis and phagosomal fate of surface-modified microparticles in dendritic cells and macrophages Pharmaceutical Research 2003 20 2 221 228
129. Ali O. A., Mooney D. J., Sustained GM-CSF and PEI condensed pDNA presentation increases the level and duration of gene expression in dendritic cells Journal of Controlled Release 2008 132 3 273 278
130. Cubillos-Ruiz J. R., Engle X., Scarlett U. K., Martinez D., Barber A., Elgueta R., Wang LI., Nesbeth Y., Durant Y., Gewirtz A. T., Sentman C. L., Kedl R., Conejo-Garcia J. R., Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity Journal of Clinical Investigation 2009 119 8 2231 2244
131. Vujanovic L., Ranieri E., Gambotto A., Olson W. C., Kirkwood J. M., Storkus W. J., IL-12p70 and IL-18 gene-modified dendritic cells loaded with tumor antigen-derived peptides or recombinant protein effectively stimulate specific Type-1 CD4+ T-cell responses from normal donors and melanoma patients in vitro Cancer Gene Therapy 2006 13 8 798 805
132. Tong X. M., Zheng S. E., Bader A., Yao H. P., Wu N. P., Altmeyer P., Brockmeyer N. H., Jin J., Construction of expression vector of HTERT- HIL18 fusion gene and induction of cytotoxic T lymphocyte response against hTERT European Journal of Medical Research 2008 13 1 7 14
133. Mannherz O., Mertens D., Hahn M., Lichter P., Functional screening for proapoptotic genes by reverse transfection cell array technology Genomics 2006 87 5 665 672
134. Okazaki A., Jo J. I., Tabata Y., A reverse transfection technology to genetically engineer adult stem cells Tissue Engineering 2007 13 2 245 251
135. Holladay C., Keeney M., Greiser U., Murphy M., O'Brien T., Pandit A., A matrix reservoir for improved control of non-viral gene delivery Journal of Controlled Release 2009 136 3 220 225
136. Lei Y., Segura T., DNA delivery from matrix metalloproteinase degradable poly(ethylene glycol) hydrogels to mouse cloned mesenchymal stem cells Biomaterials 2009 30 2 254 265
137. Jang J. H., Bengali Z., Houchin T. L., Shea L. D., Surface adsorption of DNA to tissue engineering scaffolds for efficient gene delivery Journal of Biomedical Materials Research A 2006 77 1 50 58
138. Frankenberger B., Regn S., Geiger C., Noessner E., Falk C. S., Pohla H., Javorovic M., Silberzahn T., Wilde S., Buchner A., Siebels M., Oberneder R., Willimsky G., Pezzutto A., Blankenstein T., Schendel D. J., Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells World Journal of Urology 2005 23 3 166 174
139. Zhu X. P., Chen Z. Z., Hu J. D., Li C. T., Yang T., Xu Z. S., Induction of anti-lymphoma cytotoxic T cell effect by dendritic cells transfected with recombinant adenovirus vectors carrying survivin gene Zhongguo Shi Yan Xue Ye Xue Za Zhi 2007 15 3 591 593
140. Xiong W., Candolfi M., Liu C., Ghulam Muhammad A. K. M., Yagiz K., Puntel M., Moore P. F., Avalos J., Young J. D., Khan D., Donelson R., Pluhar G. E., Ohlfest J. R., Wawrowsky K., Lowenstein P. R., Castro M. G., Human Flt3L generates dendritic cells from canine peripheral blood precursors: implications for a dog glioma clinical trial PLoS One 2010 5 6
141. Smits E. L., Anguille S., Cools N., Berneman Z. N., Van Tendeloo V. F., Dendritic cell-based cancer gene therapy Human Gene Therapy 2009 20 10 1106 1118